In the November/December 2021 Issue of Drug Development and Delivery, HCmed Innovations shares that biologic drugs are increasingly being investigated for delivery with inhalation therapy, which has initiated more in-depth discussions about the implications of formulation development and their pairing with adequate inhaled devices for more efficient treatment outcomes.

To access the article click here or email us to info@hcmed-inno.com.